256P Difference of immunological status and response to immune checkpoint inhibitor between recurrent and de novo stage IV HER2-negative breast cancer in NEWBEAT trial (WJOG9917BTR)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 33; p. S654
Main Authors Ozaki, Y., Kitano, S., Yamashita, M., Ikarashi, D., Tsurutani, J., Iwasa, T., Takahashi, M., Mukohara, T., Masuda, N., Futamura, M., Minami, H., Matsumoto, K., Tanabe Hashimoto, Y., Kawabata, H., Yoshimura, K., Takano, T.
Format Journal Article
LanguageEnglish
Published 01.09.2022
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2022.07.295